|
C3ORF63 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.598800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.445000E-01 |
| Normal-vs-Stage2 |
6.672800E-01 |
| Normal-vs-Stage3 |
6.798300E-02 |
| Normal-vs-Stage4 |
2.751800E-01 |
| Stage1-vs-Stage2 |
9.221000E-01 |
| Stage1-vs-Stage3 |
1.359560E-01 |
| Stage1-vs-Stage4 |
6.231400E-01 |
| Stage2-vs-Stage3 |
3.150800E-01 |
| Stage2-vs-Stage4 |
6.847200E-01 |
| Stage3-vs-Stage4 |
4.628400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.143400E-01 |
| Normal-vs-AfricanAmerican |
5.519900E-02 |
| Normal-vs-Asian |
3.752800E-01 |
| Caucasian-vs-AfricanAmerican |
2.354200E-01 |
| Caucasian-vs-Asian |
2.546400E-01 |
| AfricanAmerican-vs-Asian |
7.895900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.786240E-01 |
| Normal-vs-Female |
3.721600E-01 |
| Male-vs-Female |
5.537000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.194800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.830200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.871600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.658800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.410600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.316000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.772100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.890800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.046100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.031900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.136400E-01 |
| Normal-vs-Grade 2 |
9.039800E-01 |
| Normal-vs-Grade 3 |
4.175700E-03 |
| Normal-vs-Grade 4 |
2.076000E-01 |
| Grade 1-vs-Grade 2 |
1.846370E-01 |
| Grade 1-vs-Grade 3 |
2.583200E-03 |
| Grade 1-vs-Grade 4 |
6.674400E-02 |
| Grade 2-vs-Grade 3 |
7.842800E-04 |
| Grade 2-vs-Grade 4 |
1.300350E-01 |
| Grade 3-vs-Grade 4 |
3.489000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.266000E-01 |
| Normal-vs-ccB subtype |
5.795400E-01 |
| ccA subtype-vs-ccB subtype |
9.741600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.801800E-01 |
| Normal-vs-N1 |
5.053600E-01 |
| N0-vs-N1 |
7.701800E-01 |
|
|
